Cargando…
Optimal staging system for predicting the prognosis of patients with hepatocellular carcinoma in China: a retrospective study
BACKGROUND: Several staging systems have been developed to evaluate patients with hepatocellular carcinoma (HCC), including the China Staging System (CS), the American Joint Committee on Cancer (AJCC) tumor-node-metastasis (TNM) staging system, and seventh edition; the Barcelona Clinic Liver Cancer...
Autores principales: | Su, Lihui, Zhou, Tao, Zhang, Zongli, Zhang, Xiuguo, Zhi, Xuting, Li, Caixia, Wang, Qingliang, Jia, Chongqi, Shi, Wenna, Yue, Yanqiu, Gao, Yanjing, Cheng, Baoquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937540/ https://www.ncbi.nlm.nih.gov/pubmed/27387757 http://dx.doi.org/10.1186/s12885-016-2420-0 |
Ejemplares similares
-
An Integrating Immune-Related Signature to Improve Prognosis of Hepatocellular Carcinoma
por: Zhu, Rui, et al.
Publicado: (2020) -
HBV is a risk factor for poor patient prognosis after curative resection of hepatocellular carcinoma: A retrospective case–control study
por: Li, Zhonghu, et al.
Publicado: (2016) -
The Impact of Socioeconomic Status on Staging, Prognosis in Hepatocellular Carcinoma
por: Zhou, Yongjie, et al.
Publicado: (2022) -
Identification of Gene Signatures for Diagnosis and Prognosis of Hepatocellular Carcinomas Patients at Early Stage
por: Gan, Xiaoning, et al.
Publicado: (2020) -
SRC-1 and Twist1 Expression Positively Correlates with a Poor Prognosis in Human Breast Cancer
por: Xu, Yan, et al.
Publicado: (2014)